Skip to main content
. 2023 Apr 28;9(5):e15865. doi: 10.1016/j.heliyon.2023.e15865

Table 1.

Neuropsychological assessment used in the study.

TEST Description Score
MMSE Mini Mental State Examination: global cognitive assessment Score 0–30;
0-8: severe cognitive impairment
9-17: moderate cognitive impairment
18-24: mild cognitive impairment
FAB Frontal Assessment Battery: executive functions assessment Score 0–18; pathological score ≤12.03
RVLT-I Rey's auditory Verbal Learning Test-Immediate Recall: verbal episodic memory (immediate recall) Score 0–75; pathological score ≤28.53
RVTL-D Rey's auditory Verbal Learning Test-Delayed Recall: verbal episodic memory (delayed recall) Score 0–15; pathological score ≤4.69
CPM Raven's Colored Progressive Matrices: visual-spatial reasoning abilities Score 0–36; pathological score ≤18.96
SWCT-time Stroop Word-Color Interference test: selective attention and processing speed assessment Pathological score ≥36.92
SWCT-errors Stroop Word-Color Interference test: cognitive flexibility and ability to inhibit cognitive interference Pathological score ≥4.24
Attentional Matrices Visual attention assessment Score 0–60;
Pathological score ≤30
PMT Prose Memory test: verbal memory assessment Score 0–28;
Pathological score ≤7.5
CGD Copying Geometric Drawings: visual spatial ability Pathological score ≤7.17
QoL-AD Quality of life in Alzheimer's Disease: quality of life assessment in adults with cognitive impairment Score: 0–100; the higher the score, the better the perceived quality of life
ADL Activity of Daily Living: independence in activities of daily living Score 0–6: the higher the score, the lower the independence of patient
IADL Instrumental Activity of Daily Living independence in instrumental activities of daily living Score 0–8: the higher the score, the lower the independence of patient